医用三氧大自血疗法治疗急性脑梗死的临床观察

Clinical observatiaon on treatment of actue cerebral infraction with medical oxygen big autohemotherapy

目的研究医用三氧大自血疗法对急性脑梗死患者神经功能缺损影响,探索三氧对提高脑梗死患者治愈及改善生活质量的效果。方法将急性脑梗死患者随机分为治疗组及对照组,两组均给予抗血小板聚集及静脉改善循环基础治疗,治疗组在此基础上加用医用三氧大自血疗法,诊治当日起开始治疗,每日1次,连续治疗5日。分别记录患者入院当日及第7日NIHSS评分及MRS评分,治疗当日、第15天及第6个月行相关血化验。结果急性脑梗死患者接受三氧大自血疗法组的预后明显好于对照组(P<0.01),其中发病24 h内接受三氧大自血回输治疗的患者预后明显好于发病24 h之后接受该疗法的患者(P<0.01)。实验组较对照组TC、TG及LDL-C下降趋势更明显,尤其在治疗后第15天,即急性期的血脂下降趋势明显。结论脑梗死急性期在常规治疗的基础上加用三氧大自疗法,可显著改善患者神经功能缺损,值得临床推广应用。

Objective To study the effect of self-blood therapy with medicaltrioxide on neurologic deficits in patients with acutecerebralinfarction, and explore the effect O3 on improving the cure and quality of life in patients with cerebralinfarction. Methods Thepatients with acute cerebralinfarction were randomly divided into treatment group and control group. Both groups were given anti-platelet aggregation and venous amelioration of basic treatment of circulation. On this basis,the treatment group was treated with self-blood therapy of medical trioxide, starting from the day of diagnosis and treatment, once a day for five consecutive days, NIHSS scoreand MRS score were recorded on the day of admission and 7 th day.Related blood tests were performed on the day of treatment, the15 thday and the6 th month after treatment. Results The prognosis of the patients with acute cerebralinfarction who received the threeoxygen and big autohemotherapy was better than that in the control group(P<0.01). The prognosis of the patients who received TTEwithin 24 hours after onset was significantly better then that of the control group(P<0.01). The decrease of TC, TG and LDL-C wasmore significant in the experimental group than in the control group. Especially on the 15 th day after treatment, the decreasing trendof blood lipid in the acute stage of acute cerebralinfarction. Conclusion The treatment of cerebralinfarction with self-therapy of threeoxygen can significantly improve the mental function of patients with good political governance, and is worthy of clinical application.